BioSpace News Archive

Invitae Corporation, a leading medical genetics company, announced preliminary financial and operating results for the second quarter ended June 30, 2021 and increases 2021 guide to revenue between $475-$500 million for the year.

89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, announced that Company’s Management will participate in the following upcoming investor conferences in August:

Abbott today announced it has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company’s new Ultreon Software.

Yuyu Pharma, a pharmaceutical company based in Korea, and Novartis Korea announced today that the companies have entered into an agreement in which Yuyu will have exclusive distribution rights for the following prescription medicines in Korea: Lamisil® for the treatment of athlete’s foot; Lescol® XL for the treatment of dyslipidemia; and the Tegretol® for the treatment of epilepsy.

Meissa Vaccines announced today the appointment of Robert Walker, M.D., as Chief Medical Officer.

Personal Genome Diagnostics Inc. today announced the appointment of Jamie Platt, Ph.D., as Chief Operations Officer.

Veranex today announced the acquisition of Experien Group, a leading provider of a full range of regulatory, quality, and clinical consulting services to medtech companies.

Allegro Ophthalmics today announced that the results of the company’s U.S. Phase 2a risuteganib non-exudative age-related macular degeneration (dry AMD) study are published in Ophthalmic Surgery, Lasers, and Imaging (OSLI) Retina.

Moderna, Inc.today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for mRNA-1345, its investigational single-dose mRNA vaccine against respiratory syncytial virus (RSV) in adults older than 60 years of age.

InMode Ltd. today announced that management will participate in the following upcoming conferences: Canaccord Genuity’s 41st Annual Growth Virtual Conference Yair Malca , Chief Financial Officer, will participate in a virtual fireside chat on August 12 at 11:30 am. ET